日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correlation of patient reported outcomes and physical exam screening for pelvic floor dysfunction: An opportunity for improved quality of life during chemoradiotherapy for cervical cancer

患者报告结局与盆底功能障碍体格检查筛查的相关性:改善宫颈癌放化疗期间生活质量的机会

Badwan, Sarah N; McKinnish, Tyler R; Massad, L Stewart; Markovina, Stephanie; Contreras, Jessika; Schwarz, Julie; Brim, Karry; Sanders, Brooke E; Kuroki, Lindsay M; Hagemann, Andrea R; McCourt, Carolyn K; Thaker, Premal H

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial

帕博利珠单抗联合化疗治疗晚期或复发性子宫内膜癌:NRG GY018 3期随机试验的总生存期和探索性分析

Eskander, Ramez N; Sill, Michael W; Beffa, Lindsey; Moore, Richard G; Hope, Joanie M; Musa, Fernanda B; Mannel, Robert S; Shahin, Mark S; Cantuaria, Guilherme H; Girda, Eugenia; Lokich, Elizabeth; Kavecansky, Juraj; Leath, Charles A 3rd; Gien, Lilian T; Hinchcliff, Emily M; Lele, Shashikant B; Landrum, Lisa M; Backes, Floor; O'Cearbhaill, Roisin E; Baghdadi, Tareq Al; Hill, Emily K; Thaker, Premal H; John, Veena S; Welch, Stephen; Fader, Amanda N; Powell, Matthew A; Aghajanian, Carol

Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

阿伐替尼±德法替尼治疗复发性低级别浆液性卵巢癌的疗效和安全性:ENGOT-OV60/GOG-3052/RAMP 201研究的主要分析

Banerjee, Susana N; Van Nieuwenhuysen, Els; Aghajanian, Carol; D'Hondt, Véronique; Monk, Bradley J; Clamp, Andrew; Prendergast, Emily; Oaknin, Ana; Ring, Kari; Colombo, Nicoletta; Holloway, Robert W; Rodrigues, Manuel; Chon, Hye Sook; Gourley, Charlie; Santin, Alessandro D; Thaker, Premal H; Gennigens, Christine; Newman, Gregg; Salinas, Erin; Youssoufian, Hagop; Moore, Kathleen N; Lustgarten, Stephanie; O'Malley, David M; Van Gorp, Toon; Grisham, Rachel N

Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response

新辅助化疗前后卵巢癌的多组学特征分析揭示了肿瘤发生和化疗反应的介质

Valentine, Mark C; Mullen, Mary M; Kotnik, Emilee N; Powell, Matthew A; Thaker, Premal H; McCourt, Carolyn K; Kuroki, Lindsay M; Hagemann, Andrea R; Arend, Rebecca C; Holehouse, Alex S; Mitra, Robi; Mutch, David G; Fuh, Katherine C

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.

磷酸化RPA2可预测同源重组功能正常的卵巢癌对铂类和PARP抑制剂的反应

Schab Angela, Compadre Amanda, Drexler Rebecca, Loeb Megan, Rodriguez Kevin, Brill Joshua, Harrington Shariska, Sandoval Carmen, Sanders Brooke, Kuroki Lindsay, McCourt Carolyn, Hagemann Andrea R, Thaker Premal, Mutch David, Powell Matthew, Serra Violeta, Hagemann Ian S, Walts Ann E, Karlan Beth Y, Orsulic Sandra, Fuh Katherine C, Sun Lulu, Verma Priyanka, Lomonosova Elena, Zhao Peinan, Khabele Dineo, Mullen Mary M

Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

帕博利珠单抗联合盆腔放化疗治疗局部晚期宫颈癌的安全性和可行性最新进展

Duska, Linda R; Petroni, Gina R; Thaker, Premal H; Crane, Erin K; Holman, Laura L; Armstrong, Debrorah K; Romano, Kara; Scalici, Jennifer

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)

高肿瘤突变负荷、高微卫星不稳定性以及错配修复缺陷患者的分子特征(按种族和民族划分):来自多机构子宫内膜癌分子靶向治疗联盟 (ECMT2) 的真实世界数据

Lee, Sarah S; Secord, Angeles Alvarez; Friedman, Steven; Hade, Erinn M; Smitherman, Carson; Bisht, Nikita; Borden, Lindsay; Jackson, Amanda L; Backes, Floor; Thaker, Premal; Arend, Rebecca; Wright, Jason D; Corr, Bradley; Ko, Emily; Konecny, Gottfried; Podwika, Sarah; Bae-Jump, Victoria; Hacker, Kari E; Pothuri, Bhavana

Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol

前瞻性评估腹膜恶性细胞学在子宫内膜癌预后中的意义:一项基于 GOG-210 方案的 NRG 肿瘤/妇科肿瘤协作组研究

Matsuo, Koji; Enserro, Danielle M; Wright, Jason D; Roman, Lynda D; Powell, Matthew A; Miller, David S; Nagel, Christa I; Thaker, Premal H; Mannel, Robert S; Stuckey, Ashley R; Guntupalli, Saketh R; Sukumvanich, Paniti; Geller, Melissa A; Vargas, Roberto; Konecny, Gottfried E; Warshal, David P; Tewari, Krishnansu S; Spirtos, Nick M; Pothuri, Bhavana; Creasman, William T; Mutch, David G

The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201

阿伐替尼联合法伐替尼治疗复发性低级别浆液性卵巢癌:ENGOT-OV60/GOG-3052/RAMP 201 II期临床试验的简明摘要

Banerjee, Susana N; Van Nieuwenhuysen, Els; Aghajanian, Carol; D'Hondt, Véronique; Monk, Bradley J; Clamp, Andrew; Prendergast, Emily; Oaknin, Ana; Ring, Kari; Colombo, Nicoletta; Holloway, Robert W; Rodrigues, Manuel; Chon, Hye Sook; Gourley, Charlie; Santin, Alessandro D; Thaker, Premal H; Gennigens, Christine; Newman, Gregg; Salinas, Erin; Youssoufian, Hagop; Moore, Kathleen N; Lustgarten, Stephanie; O'Malley, David M; Van Gorp, Toon; Grisham, Rachel N

Diverse case series of granulomatous peritonitis mimicking advanced ovarian cancer

一系列肉芽肿性腹膜炎病例,其临床表现酷似晚期卵巢癌

Furuya, Rachel L; Rimel, Bobbie J; Tsai, Richard; Brooks, Rebecca Ann; Stewart Massad, L; Thaker, Premal H; Pfeifer, John D